Artelo Biosciences ARTL
NASDAQ ARTL
$3.68 -0.15 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Accumulated Expenses (2017 - 2025)

Updated

Artelo Biosciences (ARTL) reported Accumulated Expenses of $11,000 for Q4 2025, down 76.1% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Accumulated Expenses (2017 - 2025) Analysis & Trends

Dating back to Q2 2017, Artelo Biosciences' Accumulated Expenses record includes 5 quarters.

  • The Q4 2025 figure ranks as the lowest quarterly Accumulated Expenses since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Artelo Biosciences 76,308.92 -5.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11,000.00
Sep 30, 2025 46,000.00
Jun 30, 2025 18,000.00
May 31, 2017 1,603.00
Feb 28, 2017 847.00
API Access

Artelo Biosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY